ContributorsPublishersAdvertisers

Roundtable Discussion: Vesole Looks at Treatment Options in Transplant-Eligible Multiple Myeloma

targetedonc.com
 2021-10-07

Cover picture for the articleA 51-year-old man presented with worsening fatigue on exertion and pallor with an ECOG performance score of 1. He eventually received a diagnosis of stage II standard-risk multiple myeloma after testing and examination. During a Targeted OncologyTM Case-Based Roundtable event, David H. Vesole, MD, PhD, the director of the...

www.targetedonc.com

Comments / 0

Comments / 0